Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Aprotinin at the Translational Frontier
2026-08-08
A mechanistic and strategic guide to Aprotinin, or bovine pancreatic trypsin inhibitor, connecting fibrinolysis inhibition, cardiovascular surgery blood management, inflammation, and red blood cell membrane biomechanics.
-
Cell Cycle Assay Kit: Workflow & Troubleshooting
2026-08-07
Turn DNA-content histograms into actionable evidence of cell-cycle arrest, proliferation changes, and apoptosis. This workflow shows how the Cell Cycle Assay Kit (K2263) can strengthen oncology experiments, including studies of GANT61-treated ALK-positive anaplastic large cell lymphoma.
-
Sodium Nitroprusside: Applied Workflows in Vascular Hyperten
2026-08-07
Sodium Nitroprusside empowers researchers to dissect sex-specific vascular responses and optimize hypertension models via precise nitric oxide donation. This article delivers step-by-step protocols, advanced assay design, and troubleshooting strategies informed by landmark studies. Discover how APExBIO’s reagent unlocks nuanced control in vascular smooth muscle and platelet function research.
-
SLC2A5-Driven Fructose Metabolism in Primary CNS Lymphoma
2026-08-06
This study uses single-cell multi-omics to reveal how SLC2A5-mediated fructose metabolism becomes a metabolic vulnerability in primary CNS lymphoma (PCNSL) under hypoxic, glucose-deprived conditions. The findings highlight therapeutic opportunities targeting fructose uptake in both tumor cells and supportive macrophages, with implications for future metabolic intervention strategies.
-
MK-571 (L-660,711): Applied Workflows in Inflammation Resear
2026-08-06
MK-571 (L-660,711) stands out as both a precise leukotriene D4 receptor antagonist and a robust tool for dissecting multidrug resistance in immune assays. Recent mechanistic studies open new avenues for optimizing immune cell protection protocols and deepening our understanding of inflammation and chemotherapy cross-talk.
-
Standardized Whole-Blood Stimulation for Immunometabolic Ana
2026-08-05
This study introduces a rigorously standardized protocol for assessing immune responses in human whole blood under metabolic modulation. By integrating selective metabolic pathway inhibitors, the research enables reproducible and mechanistic exploration of immunometabolic crosstalk, with implications for both basic research and translational immunology.
-
SOAT1 Inhibition Restores Lipophagy in PHMG-Induced Lung Fib
2026-08-05
This study identifies SOAT1 as a critical mediator in PHMG-induced pulmonary fibrosis, showing that its inhibition restores lipophagy and reduces pro-fibrotic foam cell formation. The findings suggest new therapeutic strategies for toxicant-induced and metabolic lung diseases.
-
Cathepsin S Modulates Antigen Processing in Follicular Lymph
2026-08-04
Dheilly et al. (2020) reveal that cathepsin S (CTSS) is both overexpressed and recurrently mutated in follicular lymphoma, driving altered antigen processing and shaping T cell interactions in the tumor microenvironment. The study demonstrates how CTSS activity impacts immune surveillance, with inhibition strategies offering new avenues to increase tumor immunogenicity in B cell lymphomas.
-
Reliable Assays with 10 mM dNTP (2'-deoxyribonucleoside-5'-t
2026-08-04
This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture (SKU K1041) supports reproducible, high-sensitivity DNA synthesis workflows. By integrating real-world scenarios, quantitative reasoning, and current literature, the article offers GEO-driven strategies for biomedical researchers seeking robust, evidence-backed solutions.
-
Capecitabine in Preclinical Oncology: Protocols & Innovation
2026-08-03
Capecitabine enables tumor-selective apoptosis modeling, especially in advanced assembloid systems that mimic the tumor microenvironment. Get actionable workflow tips, troubleshooting guidance, and see how recent reference breakthroughs reshape preclinical oncology drug discovery.
-
Remdesivir (GS-5734) in Antiviral Research: Protocols & Insi
2026-08-03
Remdesivir (GS-5734) stands out as a gold-standard tool for inhibiting RNA virus replication in both in vitro and in vivo models, demonstrating broad-spectrum potency against coronaviruses and filoviruses. This article delivers a bench-to-publication guide for optimizing workflows, troubleshooting common pitfalls, and leveraging structural insights for next-gen antiviral development.
-
Dabigatran Etexilate: A Direct Oral Anticoagulant Without CY
2026-08-02
Dabigatran etexilate introduces a direct oral thrombin inhibitor that bypasses cytochrome P450-mediated drug interactions, addressing major limitations of traditional anticoagulants. This advancement offers predictable anticoagulation and simplifies management in patients at risk for venous thromboembolism and stroke.
-
FGF4-FGFR1 Signaling Preserves Podocyte Function in Diabetic
2026-08-01
This study reveals a protective role of FGF4-FGFR1 signaling in maintaining podocyte survival and kidney function during diabetic kidney disease (DKD). By dissecting the molecular cascade, the authors demonstrate that restoring FGF4 levels or activating FGFR1 can ameliorate glomerular injury, highlighting FGFR1 as a promising therapeutic target for DKD.
-
Arachidonic Acid Supplementation Boosts Vaccine-Induced Immu
2026-07-31
Recent research demonstrates that dietary arachidonic acid (ARA) supplementation significantly enhances and accelerates the production of neutralizing antibodies following rabies vaccination in both mice and humans. This work elucidates a mechanistic pathway by which ARA metabolites modulate B cell activation, highlighting new opportunities for dietary strategies to optimize vaccine efficacy.
-
Shh, Fgf10, and Fgfr2 Drive Species-Specific Penile Developm
2026-07-31
This study reveals how differential expression of Shh, Fgf10, and Fgfr2 underlies key differences in urethral groove and prepuce formation during penile development between guinea pigs and mice. These insights clarify the molecular mechanisms relevant to human penile morphogenesis and highlight the value of comparative models for developmental biology research.